# Bioequivalence Study of Letrozole 2.5 mg Tablets

> **NCT01084499** · NA · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Femara (Sequence 1)
- **DRUG:** Peratra (Sequence 1)
- **DRUG:** Femara (Sequence 2)
- **DRUG:** Peratra (Sequence 2)

## Key facts

- **NCT ID:** NCT01084499
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084499, "Bioequivalence Study of Letrozole 2.5 mg Tablets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01084499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*